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Early intervention for conversion disorder:
neurologists and psychiatrists working
together
Aybek S, Hubschmid M, Mossinger C, Berney A, Vingerhoets F. Early
intervention for conversion disorder: neurologists and psychiatrists
working together.
Objective: To evaluate the efficacy of an early multidisciplinary
(neurology and psychiatry) intervention for conversion disorder (CD).
Methods: Consecutive patients newly diagnosed with CD from 2005 to
2007 were compared to a control group of newly diagnosed CD patients
receiving usual care. At 3 years, a questionnaire evaluated self-rated
subjective outcome, symptom severity, SF-36 scores, employment status
and medical care use.
Results: Data from 12 cases (mean age 25.5 ± 8.2; 9 females) and 11
controls (mean age 34.7 ± 13.5; 10 females) showed that 83% of cases had
a good subjective outcome (symptom improved or cured) when only 36%
of controls had a good outcome (p< 0.05). Cases significantly improved
their SF-36 scores on subscales involving physical complaints compared to
controls. A minority (20%) of cases reduced or ceased professional
activity when 70% of controls did (p< 0.001). Only 16% of cases sought
further medical advice for the initial symptom when 73% of controls did.
Both groups accepted psychiatric referrals (83% of cases and 73% of
controls) and found it beneficial.
Conclusions: Early intervention involving both neurologists and
psychiatrists is effective for CD in alleviating physical complaints,
reducing sick leave and health care use.
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Significant outcomes
• A high proportion (73–83%) of conversion disorder patients accept psychiatric referral.
• Only patients who had a structured multidisciplinary joint programme (psychiatric and neurological
follow-ups) had a long-term (3 years) good outcome.
• Unstructured psychiatric treatment alone is not sufficient for conversion disorder, that seem to benefit
from an early support involving both psychiatric and neurological interventions.
Limitations
• The results of this study are highly significant but rely on a small sample of patients and might not be
generalised to other conversion disorder population.
• The two groups were not randomised and a selection bias could have happened towards better cases
allocated to the treatment group.
• The outcome measures rely on patient’s report and are prone to subjective evaluation.
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Introduction
Functional neurological symptoms are frequently
encountered in neurology (1) and represent an enor-
mous challenge in terms of treatment, as they bear a
poor prognosis (2) and are costly in terms of health
care system (3) and employment (4). Despite spectac-
ular advances in neuroscience, no definite biological
aetiologic model has emerged (5) and functional neu-
rological symptoms are understood as ‘psychogenic’
(6) or thought to be part of psychiatric illnesses, as
reflected by both DSM-IV conversion disorders (CD)
or CIM-10 dissociative disorders definitions. Neurol-
ogists often refer patients with functional symptoms
to psychiatrists (7) and both specialists admit they
find those patients difficult to handle (8). Several
psychosocial therapeutic approaches have been tried
such as hypnosis (9), paradoxical injunction therapy
(10), individually tailored psychotherapy (11) and
cognitive behavioural therapy (12), but no definite
treatment plan can be recommended (13). One of
the major difficulties in those approaches lies in the
fact that patients do not see themselves as psychiatric
patients (14), as they suffer from a physical symp-
tom. When a psychiatric referral is offered, they feel
rejected by their neurologists and tend to seek further
medical advice (15). A multimodal approach – com-
bining physical revalidation and psychological inter-
vention has shown some benefit in CD (16). In this
context and in order to avoid the above mentioned
issues, a joint consultation, including a neurologist
and a psychiatrist, was implemented in our tertiary
centre in 2005 (University Hospital, Lausanne), ded-
icated to the management of patients diagnosed with
CD.
The aim of this study was to evaluate the impact
of this treatment plan on the long-term outcome of
patients.
Methods
Subjects selection: ‘Joint consultation group’
All consecutive patients followed at the joint consul-
tation from 1 January 2005 to 30 September 2007
were included. They were all newly diagnosed with
CD (DSM-IV criteria) after thorough neurological
and psychiatric assessments. The treatment plan con-
sisted of a neurological follow-up assessment, fol-
lowed by a psychiatric interview and at the end a
common discussion with the patient, the neurologist
and the psychiatrist was held. No predefined number
of consultations was set but the treatment plan was
tailored to the patient needs. The aim of the joint
consultation was to explain the functional nature of
the symptoms, offer coping strategies and address the
potential role of psychological factors.
Controls selection: ‘Standard care control group’
Patients with new onset CD who were not followed
up at the joint consultation during the same period
were identified through retrospective chart review of
all in- and outpatients. Electronic patients database
was reviewed with the search terms ‘psychogenic’,
‘functional’, ‘dissociative’, ‘somatoform’ and ‘con-
version’. Once a diagnosis was established, patients
were discharged with a summary to their general
practitioner, stating the diagnosis and suggesting psy-
chiatric referral.
Intervention
A postal questionnaire was sent in December 2009
to all subjects, and phone calls were made to those
who did not respond to either confirm their refusal or
propose them to fill in the questionnaire by phone.
The questionnaire included the SF-36, employment
status, medical care use and self-ratings of symptoms
severity. Subjects were asked to rate on a 0–10
Likert scale how severe their symptoms were at first
presentation and how severe they were at the time of
questionnaire.
Analysis
Across group analysis were done by comparing the
mean or median scores with Mann-Whitney U -tests.
Between group analysis of score changes over time
were done with paired Wilcoxon test.
Results
From 1 January 2005 to 30 September 2007, 17
patients were enrolled in the joint consultation
programme. Two patients were lost to follow-up, 3
refused and 12 responded.
During the same period, 28 charts were identified
with the above mentioned search terms but only 17
fulfilled the DSM-IV criteria for CD. In the other
cases, search terms were present because CD was
raised in the differential diagnosis. Two subjects were
lost to follow-up, 4 refused to take part and 11
responded.
Demographic data did not differ between groups,
which had similar female/male ratio and symptom
types (Table 1). The joint consultation group tended
to be younger but the mean age was not significantly
different between groups (25.5 ± 8.2; 34.7 ± 13.5;
p = 0.07 for joint consultation and standard care
groups, respectively). The median time from first
symptom to diagnosis was similar in both groups
(11 days; 14 days; p = 0.81), as well as the time
elapsed from diagnosis to follow-up questionnaire
(3.6 years; 3.1 years; p = 0.09). The joint consultation
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Table 1. Demographic and outcome data
Demographic data Joint consultation group (n = 12) Standard care group (n = 11) p values
Gender (Female : Male) 9 : 3 10 : 1
Type of symptom 5 motor deficit 6 motor deficit
2 gait 3 gait
5 movement disorders 1 movement disorders
1 visual disorder
Mean age at first symptom (years) 25.5 ± 8.2 34.7 ± 13.5 ns (p = 0.07)
Median time from first symptom to diagnosis (days) (25–75th
percentile)
11 (7–50) 14 (7–85) ns (p = 0.81)
Median time from diagnosis to questionnaire
(years)(25–75th percentile)
3.6 (2.8–4.2) 3.1 (2.4–3.3) ns (p = 0.09)
Mean nb of joint consultations 2.8 ± 1.9 (range 1–6) Not applicable
Outcome data Joint consultation group (n = 12) Standard care group (n = 11) p values
Self-rated outcome (% of patients) Good outcome: 83% Good outcome : 36% p = 0.005∗
6 (50%) cured 0 (0%) cured
4 (33%) better 4 (36%) better
Bad outcome : 16% Bad outcome: 63%
1 (8%) stable 3 (27%) stable
1 (8%) worse 4 (36%) worse
Initial symptom severity (0–10 Likert scale) (median) 9 (range 2–10) 8 (2–10) ns (p = 0.64∗)
Follow-up symptom severity (0–10 Likert scale) (median) 1 (range 0–8) 7 (3.5–10) p = 0.001∗
Change of symptom (baseline to follow-up) From 9 to 1 – p = 0.002†
– From 8 to 7 ns (p = 0.34†)
Nb of patients who reduced or ceased professional activity
due to symptom (amongst those who had a professional
activity at baseline)
2/10 (20%) 7/10 (70%) p = 0.019∗
Understanding of disease Joint consultation group (n = 12) Standard care group (n = 11) p value
Nb patients who considered initial diagnosis unclear 6/12 (50%) not at all clear or rather unclear 9/11 (82%) not at all clear or rather unclear ns (p = 0.12∗)
Nb patients who sought further medical investigations 2/12 (16%) 8/11 (73%) p = 0.008∗
1 GP 2 NLG
1 GP + NLG + RHUMAT 1 NLG + RHUMA + GP + GYN
1 RHUMA
1 GP
1 GP + OPTH
1 GASTRO
1 ORTHO
Nb patients who attended psychiatric referral 10/12 (83%) 8/11 (73%) ns (p = 0.55∗)
Mean number of psychiatric consultations 41 ± 37 44 ± 30 ns (p = 0.8)
Psychiatry judged beneficial 9/10 (90%) beneficial 8/8 (100%) beneficial ns (p = 0.78∗)
2 slightly 1 slightly
2 very 5 very
5 extremely 2 extremely
1/10 (10%) not at all beneficial 0/8 (0%) not at all beneficial
Joint consultation judged beneficial 9/12 (75%) beneficial Not applicable
6 slightly
1 very
2 extremely
3/12 (25%) not at all beneficial
SF-36 scoresMean (SD) Joint consultation (n = 12) Standard care (n = 11) p value Normal population‡ (n = 1250)
Physical functioning 83 (28) 57 (27) p = 0.021 84 (23)
Role physical 67 (39) 28 (26) p = 0.017 75 (36)
Social functioning 74 (35) 48 (25) p = 0.033 78 (22)
Bodily pain 72 (37) 47 (36) ns (p = 0.10) 72(24)
Mental health 59 (23) 44 (13) ns (p = 0.09) 68 (19)
Role emotional 67 (45) 64 (46) ns (p = 0.9 ) 74 (36)
Energy /Vitality 46 (24) 35 (18) ns (p = 0.26) 57 (18)
General health 56 (27) 25(16) p = 0.006 71 (20)
ns, non significant; NLG, neurologist; RHUMA, rheumatologist; GP, general practitioner; GYN, gynaecologist; OPTH, ophthalmologist; GASTRO, gastroenterologist; ORTHO, orthopaedist.
∗Mann-Whitney U test.
†Wilcoxon test.
‡SF-36 scores from the general local population (17).
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group had a mean number of follow-up consultations
of 2.8.
The majority of patients from the joint consultation
group reported a good long-term outcome (83%)
when only 36% of the standard care group did
(p = 0.005). Both groups rated their initial symptoms
as equally severe (9 vs. 8, p = 0.64) but only the joint
consultation group reported a significant change in
symptoms severity (from 9 to 1; p< 0.01 vs. from 8
to 7, p = 0.34). Only 20% of patients from the joint
consultation group reduced or ceased professional
activity because of initial symptoms when 70% of the
patients from the standard care group did (p< 0.05).
Patients from the joint consultation group had
better SF-36 scores on physical functioning, social
functioning, general health and less limitation of their
activities due to physical symptoms. No differences
were found in terms of mental health or limitation of
activities due to emotional symptoms, nor in energy
level or pain. To compare the SF-36 scores to what
can be expected in the general population, the normal
range in the local population (17) are presented in
Table 1 but no statistical analysis was carried out.
It appears that patients from the joint consultation
group reach a normal level for physical functioning,
even though they still have lower scores for general
health, compared to the healthy local population.
In terms of understanding the disease, both groups
considered their initial diagnosis as rather unclear
or completely unclear (50 and 82%, respectively for
the joint consultation and control group, p = 0.12)
but a significant smaller proportion of patients from
the joint consultation group sought further medical
advice (16 vs. 73%, p< 0.01) (details in Table 1).
A majority of patients in both groups agreed to
a psychiatric referral (83 vs. 73%, p = 0.55) and
considered this psychiatric intervention beneficial
(90 vs. 100%, p = 0.78). Patients from the joint
consultation group had a mean number of additional
(after the joint consultation programme was over)
psychiatric interviews of 41, when patients from the
standard care group had a mean of 44 interviews
(p = 0.9). A majority of patients followed-up in
the joint consultation judged the intervention to be
beneficial (75%).
Discussion
This controlled, questionnaire-based, follow-up study
showed that at 3 years the group of CD patients
enrolled in a standardised programme involving joint
consultations (neurologist and psychiatrist) had a
better subjective outcome with a decrease of self-
rated symptom severity, compared to standard care
patients. This improvement of physical symptoms
was also reflected in the results of the SF-36 ques-
tionnaire, showing a significant difference between
groups in the subscales involving physical com-
plaints. Objective measures, such as employment sta-
tus and medical care use also showed a benefit of this
programme, as a greater proportion of treated patients
returned to work and reduced their medical care use.
Our data show that overall, patients with CD had a
high acceptance rate for further psychiatric referral,
as both groups agreed to psychiatric evaluation with
similar numbers of follow-up consultations and even
judged it to be beneficial. However, patients who had
psychiatric treatment outside the joint consultation
programme did not improve their physical symptom.
This suggests that unspecific psychiatric intervention
is not sufficient for CD patients and that the
benefit we observe in our study might be due
to the targeted goals defined – coping strategies
and identification of psychological triggering factors.
This is in line with previous work (11) showing
that tailored psychotherapy, focussing on unresolved
issues from the past and coping styles might be
efficient in functional neurological symptoms. The
second significant finding of our study is that patients
from the joint programme reduced their health care
use compare to controls. Our structured programme
offered early standardised psychiatric intervention in
the first weeks after symptom onset, whereas we
do not have data on the time elapsed from first
symptoms to first psychiatric intervention in the
controls group. One could hypothesise that controls
had a delay in their psychiatric care that led them to
seek further medical help in the meantime. However,
as the third goal of the joint programme was to
provide reassurance that no other organic cause can
be found through repeated medical examination and
discussions with the neurologist, this effect could
also suggest that the presence of a neurologist is
crucial in providing this reassurance and that reduced
health care use is a positive consequence of this
reassurance. A better understanding of the disease
– and attribution to psychological causes – is a
recognised predictor of good outcome (18) and
one could hypothesise that the positive effect we
measure is due to an improvement of understanding
of the disease in patients followed at the joint
programme. Both groups rated their initial diagnosis
as being rather unclear and, unfortunately, our
questionnaire did not include an evaluation of disease
understanding after treatment but the reduction in
health care use is an indirect measure of acceptance
of the proposed diagnosis.
Our study has several limitations. As the con-
trol group was selected based on retrospective chart
reviews rather than randomised prospective attri-
bution, a bias could have happened towards cases
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with better prognosis allocated to the joint consul-
tation group, like patients with isolated CD without
comorbid somatization. However, no significant dif-
ferences were observed between groups at baseline
regarding the other major known prognostic factors
(2,19,20); time to diagnosis, type of symptoms or
baseline symptom severity. As all cases were newly
diagnosed, a proportion of cases might have had a
spontaneous positive outcome independent from the
intervention. However, as both groups had similar
times from first symptom to diagnosis, one could
expect this effect to be minimised. Another limitation
is that our outcome measures are subjective, as they
rely on patients’ self-reports and could have been
influenced by unrealistic recall of baseline symp-
toms severity. Finally, as the exact content of the
psychiatric intervention in the standard care group is
not available, the differences in outcome we mea-
sure might not be due only to the procedure (joint
consultation) itself as described above but could also
be partly explained by a different type of psychiatric
treatment. To better refine the effect of the psychiatric
approach, a prospective study is needed.
This study however, shows that a joint consultation
programme is well accepted by the patients, is
effective in alleviating the physical symptoms, allows
a better social functioning and reduces unnecessary
medical investigations. The proposed intervention
has minimal requirement – a psychiatrist and a
neurologist ready to work together – and in the
era of sophisticated medicine, such simple non-
invasive treatment strategies should be maintained
and developed by clinicians, as they seem to be
useful to patients and cost-effective.
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